Using gene expression profiles from patients with an identical driver mutation (t(4;11)/MLL-AF4), we first set out to determine whether infant-ALL had a distinct molecular profile compared to childhood-ALL. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.